New preclinical publication demonstrates the efficacy and mechanism of action of repeated TTS treatments (C215Fab-SEA) and that the treatment leads to a long-term antitumor immune response

Tumor-targeted superantigens produce curative tumor immunity with induction of memory and demonstrated antigen spreading. Meir Azulay, Michal Shahar, Eitan Shany, Eti Elbaz, Sveta Lifshits, Marie Törngren, Adam Friedmann, Robert Kramer & Gunnar Hedlund. Journal of Translational Medicine 2023 21:222. Read the article here.